Duke Clinical Research, Unit 200 — Durham, North Carolina

Duke Clinical Research, Unit 200 is a clinical research site located in Durham, North Carolina, United States 27705.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Clinical Research, Unit 200 has participated in 1 clinical trials.

Therapeutic areas: Anticoagulant Reversal, Reversal of Edoxaban Induced Anticoagulation.

Sponsors: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Clinical Research, Unit 200?

Duke Clinical Research, Unit 200 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Clinical Research, Unit 200 conducted?

Duke Clinical Research, Unit 200 has 1 clinical trials on record. Their work covers Anticoagulant Reversal, Reversal of Edoxaban Induced Anticoagulation.

Is Duke Clinical Research, Unit 200 accredited by Crixeo Health?

Duke Clinical Research, Unit 200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Clinical Research, Unit 200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.